RecruitingNCT04370626

The Canadian Prospective Pragmatic Perilunate Outcomes Trial

The Canadian Prospective Pragmatic Perilunate Outcomes Trial (The C3PO Trial)


Sponsor

University of Calgary

Enrollment

450 participants

Start Date

Sep 1, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

This is a unique three-fold prospective and retrospective study. With this approach, all previous and current PLIs presented at participating study sites will have the potential to be included in the study. Our goal is to collect all relevant injury and surgical parameters of the Perilunate spectrum. The investigators plan to identify each hospital within Canada that normally treats PLIs and to record injury and demographic information on each PLI that occurs in this country over a two to three-year period. Our protocol includes scheduled two, five, and 10-year follow-up intervals.


Eligibility

Min Age: 14 YearsMax Age: 120 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with carpal bone fracture, dislocation of wrist, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 14 Years to 120 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

South Health Campus

Calgary, Alberta, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04370626


Related Trials